Expression of an anti-sickling β-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells

Keyphrases

• Globin 100%
• Hematopoietic Cells 100%
• Sickle Cell Disease 100%
• Anti-sickling 100%
• Erythroblasts 100%
• Virus 50%
• Green Fluorescent Protein 50%
• Erythroid 50%
• Cord Blood Cells 50%
• Gene Transfer 33%
• Retrovirus 16%
• Cell-to-cell 16%
• Thalassemia 16%
• Gene Therapy 16%
• Protein Expression 16%
• Stem Cells 16%
• Complementary DNA (cDNA) 16%
• Myeloid Cells 16%
• Lymphoid Cells 16%
• Cell-derived 16%
• Globin Expression 16%
• Normal Human 16%
• Pseudotype 16%
• Infected Cells 16%
• SCID Mice 16%
• CD34+ 16%
• Long Terminal Repeat 16%
• Retroviral Vector 16%
• Therapy Approaches 16%
• Vector-based 16%
• Human Target 16%
• Patient Blood Samples 16%
• Primitive Cell 16%
• Vector Design 16%
• Phosphoglycerate Kinase 16%
• Cassette 16%
• Transfer Approach 16%
• Transplantable 16%
• Human Cord Blood 16%

Biochemistry, Genetics and Molecular Biology

• Globin 100%
• Hematopoietic Cell 100%
• Green Fluorescent Protein 42%
• Promoter Region 14%
• Enhancer Region 14%
• Stem Cell 14%
• Derived Protein 14%
• Retrovirus 14%
• Precursor 14%
• Normal Human 14%
• Myeloid 14%
• Protein Expression 14%
• Gene Therapy 14%
• CD34 14%
• Long Terminal Repeat 14%
• Retrovirus Vector 14%
• Hemocyte 14%
• Pseudotyping 14%
• Target Cell 14%
• Phosphoglycerate Kinase 14%
• NOD SCID Mouse 14%
• Messenger RNA 14%